CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 155 enrolled
Drug / intervention
EYE-SYNC eye-tracking device +2 moredevice
Likely dose
Not stated in record
Key inclusion· 3
  • ✓Athletes between 18-25 years old
  • ✓Vision 20/30 or better (corrected vision allowed)
  • ✓English fluency
Key exclusion· 0

None specified.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02844543
NCT02844543N/ACompleted
CompareCT.gov

EYE-TRAC Advance: Technology Verification (ETA-TV) Cohort 1

Stanford University·interventional·Posted Jul 26, 2016·Updated May 30, 2018

In Brief

A clinical study evaluating EYE-SYNC eye-tracking device, SCAT-3, and 1 other intervention for Eye-tracking. Completed, enrolled 155 participants across 1 site.

Detailed Summary

This study will assess the effects of exercise and non-concussive bodily contact on eye-tracking scores collected by the EYE-SYNC eye-tracking device.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEye-tracking
CountriesUnited States
CollaboratorsBrain Trauma Foundation, United States Department of Defense, Food and Drug Administration (FDA), U.S. Army Medical Research and Development Command, Department of Health and Human Services

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 26, 2016
Enrollment StartJan 1, 2016
Primary CompletionDec 1, 2016
TodayJul 2, 2026
Enrollment to primary: 11 monthsPosted 9.9 years ago

Interventions

EYE-SYNC eye-tracking devicedevice

The EYE-SYNC® portable eye-tracking system. The eye tracker is a handheld isolated display environment with embedded eye tracking sensors. The eye tracker is connected to a high-performance Windows tablet though a customized docking station. Included accessories with EYE-SYNC are a U.S. tablet power supply adapter and disposable sanitary masks. Participants are asked to follow a dot with their eyes, as the dot moves on the screen of the EYE-SYNC device.

SCAT-3other

The Symptom subtest of SCAT-3 assessment tool will be administered to participants.

Desktop Eye-Trackerdevice

Eye movements are recorded with an eye tracking system (Desktop Eye-Tracker, Eyelink CR, SR Research) with up to 1000 Hz temporal resolution. The target stimulus is presented on a computer screen approximately 50 cm from the participant. Participants are asked to follow a dot with their eyes, as the dot moves on the monitor screen of the desk-top eye-tracking device.